GlaxoSmithKline (Africa)

Company Overview

We are a science-led global healthcare company with a mission: we want to help people to do more, feel better, live longer.

On 2 March 2015 we completed a 3-part transaction with Novartis which reshapes our business.

We acquired Novartis’s vaccines business (excluding influenza vaccines) and combined our Consumer Healthcare businesses to create a new company. By substantially strengthening Vaccines and Consumer Healthcare, we can deliver far-reaching benefits to patients and consumers, and further value to shareholders. In addition, Novartis acquired our marketed Oncology portfolio.

The vaccines, medicines and consumer healthcare products that we research and develop can improve people’s health and well-being, ultimately helping them to live life to its fullest and contribute to the prosperity of their communities.

We ask all of our employees across the 115 countries to share our mission and consider how what they do can help all those people who rely on the products we make. It is why every day our scientists search for new ways to improve the treatment of diseases and illnesses. And it is why we have been pioneering new solutions that allow us to make our products available to those who need them, wherever in the world they live and whatever their ability to pay.

We are a business, so we need to do this in a sustainable way. But in doing this well, we deliver a profitable and sustainable performance. This in turn allows us to generate value and returns for our shareholders, while maintaining the substantial investment we make into the research and discovery, manufacturing, supply and distribution of our products that ultimately delivers value to patients and society.